Latest Idera Pharmaceuticals Inc. Stories

2008-10-01 09:00:09

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear cell renal carcinoma (RCC). The primary objective was not achieved in the study.

2008-06-16 09:00:10

Idera Pharmaceuticals (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLRs), today announced the formation of an Autoimmune Disease Scientific Advisory Board.

Word of the Day
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.